We conducted a 56-week , double-blind trial involving 3731 patients who did not have type 2 diabetes and who had a body-mass index ( BMI ; the weight in kilograms divided by the square of the height in meters ) of at least 30 or a BMI of at least 27 if they had treated or untreated dyslipidemia or hypertension .